Tuberculosis Tag

  • All
  • Advocacy Hub
  • Advocacy Update
  • Blog Posts
  • GHC Announcements
  • News Center
  • Statement
Engaging Policy Makers Ahead of the Ministerial Conference and UN High-Level Meeting on TB

Organized by

October 25
8:30 AM – 10:00 AM EDT


Join Treatment Action Group (TAG) and the Global Coalition of TB Activists (GCTA) for a webinar on how civil society and community groups can initiate a dialogue with their national governments in advance of the Ministerial Conference in Moscow. Panelists will debut new, community-developed outreach tools and share strategies to maintain an open channel for communication and accountability in the lead up to the UN High-Level Meeting on TB and beyond.

Panelists include:

1) Jeffry Acaba, ACT Asia Pacific
2) Fanny Voitzwinkler, TB Europe Coalition
3) Sharonann Lynch, Médecins Sans Frontières
4) Timur Abdullaev, TB People
5) Anele Yawa, Treatment Action Campaign

Moderator: Marcus Low, Spotlight

Overcoming Challenges in the Introduction and Scale-Up of Newer Drugs for the Treatment of Multi-Drug Resistant Tuberculosis: Lessons from the Field

Organized by  DR-TB STAT

Symposium at the 2017 Union World Conference on Lung Health
October 12
10:30 AM – 12:00 PM
Hall 9, Jalisco Hall
Guadalajara, Mexico

(Conference registration is required to attend the symposium. Register online by October 10. On-site registration available after October 10)

MSF at the 48th Union World Conference On Lung Health

Organized by


More MSF Events

EndTB Symposium: Accelerating TB Elimination Through Access to Bedaquiline and Delamanid
October 12
2:00 PM – 3:30 PM
Hall 10, Jalisco Hall
Guadalajara, Mexico

The symposium will provide an update on the UNITAID-funded endTB initiative and findings, including culture conversion and reversion and adverse events for the 600 people who have received bedaquiline or delamanid.

Community space (Encuentro) session: Five urgent improvements to DR-TB treatment
October 13
5:00 PM – 6:00 PM
Foro – Encuentro Expo
Guadalajara, Mexico

Evidence for treatment with newer DR-TB drugs, shorter treatment regimens, ambulatory care instead of hospitisation, and fast-track registration of new drugs.

MSF Symposium: Reducing Catastrophic Costs for People with TB through Patient-Centred care
October 14
10:30 AM – 12:00 PM
Hall 10, Jalisco Hall

Session will analyse the barriers to reducing costs and burden for people with drug-resistant TB including: decentralised and ambulatory treater, shorter treatment and newer drugs to reduce toxicity, and interventions to reduce out-of-pocket costs of treatment.

Show more